Serum inhibitor in systemic lupus erythematosus associated with aplastic anemia
- PMID: 6732407
Serum inhibitor in systemic lupus erythematosus associated with aplastic anemia
Abstract
Hematologic complications of systemic lupus erythematosus (SLE) usually involve peripheral destruction of blood elements. We report a case of SLE-associated aplastic anemia in which an IgG complement-dependent antibody, obtained from the patient's disease-phase serum but not remission-phase serum, suppressed growth of granulocyte-macrophage progenitor cells from bone marrow of normal donors in vitro. Therapy with plasmapheresis and immunosuppression resulted in lasting remission.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
